- Conditions
- Burn Wounds - Partial Thickness (2nd Degree)
- Interventions
- Field Shield Wound Dressing, Silverlon
- Device
- Lead sponsor
- KeriCure Medical
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • San Antonio, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 769–792
of 1,813
matching trials from the local directory fallback.
- Conditions
- Mitral Annular Calcification, Mitral Regurgitation, Mitral Stenosis, Mitral Valve Disease
- Interventions
- Transseptal ViMAC
- Device
- Lead sponsor
- Mayra Guerrero
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 210 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2030
- U.S. locations
- 16
- States / cities
- Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 12 more
- Conditions
- Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
- Interventions
- coagulation factor VIIa [recombinant]-jncw
- Drug
- Lead sponsor
- American Thrombosis and Hemostasis Network
- Network
- Eligibility
- 12 Years to 100 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 21
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 17 more
- Conditions
- Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Quadriplegia, Quadriplegia/Tetraplegia, Tetraplegia/Tetraparesis, Tetraplegic; Paralysis
- Interventions
- N1 Implant, R1 Robot
- Device
- Lead sponsor
- Neuralink Corp
- Industry
- Eligibility
- 22 Years to 75 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2031
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Miami, Florida
- Conditions
- Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult
- Interventions
- Not listed
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- Not listed
- Enrollment
- 150,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2030
- U.S. locations
- 63
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 50 more
- Conditions
- Diabete Mellitus, Foot Ulcer Chronic
- Interventions
- Placental Membrane
- Biological
- Lead sponsor
- BioXTek
- Industry
- Eligibility
- 45 Years to 85 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Houston, Texas
- Conditions
- Peripheral Arterial Diseases
- Interventions
- Auryon Atherectomy System, Balloon Angioplasty
- Device
- Lead sponsor
- Angiodynamics, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 224 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 9
- States / cities
- Phoenix, Arizona • San Diego, California • Gray, Louisiana + 6 more
- Conditions
- Symptomatic Functional MR 3 or Greater
- Interventions
- This study will evaluate the safety and functionality of the AMEND™ Trans-Septal System for annuloplasty as a therapy for mitral regurgitation.
- Device
- Lead sponsor
- Valcare Medical Ltd.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • La Jolla, California • Atlanta, Georgia + 8 more
- Conditions
- Chronic Pain
- Interventions
- Dorsal root ganglion stimulation (DRG), Spinal cord stimulation (SCS)
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,000 participants
- Timeline
- 2019 – 2029
- U.S. locations
- 30
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Larkspur, California + 24 more
- Conditions
- Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal
- Interventions
- Pegfilgrastim (drug), TORL-1-23
- Drug
- Lead sponsor
- TORL Biotherapeutics, LLC
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 230 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Duarte, California + 22 more
- Conditions
- Bladder Cancer
- Interventions
- Hexaminolevulinate hydrochloride (HCL), Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
- Drug · Device
- Lead sponsor
- Photocure
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 4,400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2028
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 18 more
- Conditions
- Diabetic Foot Ulcer, Wound Heal
- Interventions
- EDX110
- Device
- Lead sponsor
- ConvaTec Inc.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 298 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • Santa Ana, California • Vista, California + 1 more
- Conditions
- Epilepsy
- Interventions
- Tripolar electroencephalography
- Device
- Lead sponsor
- CREmedical
- Industry
- Eligibility
- 6 Years and older
- Enrollment
- 90 participants
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Boston, Massachusetts
- Conditions
- Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
- Interventions
- Adjuvant therapy, Daromun, Surgery
- Drug · Procedure
- Lead sponsor
- Philogen S.p.A.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 186 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2031
- U.S. locations
- 19
- States / cities
- Phoenix, Arizona • La Jolla, California • Orange, California + 16 more
- Conditions
- Atherosclerosis, Metformin, Prediabetic State
- Interventions
- Metformin XR, Placebo
- Drug
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 7,410 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 40
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 37 more
- Conditions
- Alzheimer's Disease, Dementia
- Interventions
- Not listed
- Lead sponsor
- Banner Health
- Other
- Eligibility
- 18 Years to 110 Years
- Enrollment
- 500,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2030
- U.S. locations
- 1
- States / cities
- Phoenix, Arizona
- Conditions
- Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8, Stage II Pancreatic Neuroendocrine Tumor AJCC v8, Stage III Pancreatic Neuroendocrine Tumor AJCC v8
- Interventions
- Capecitabine, Temozolomide
- Drug
- Lead sponsor
- SWOG Cancer Research Network
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 141 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 446
- States / cities
- Anchorage, Alaska • Fairbanks, Alaska • Gilbert, Arizona + 300 more
- Conditions
- Gastroenteritis, Pneumonia, Soft Tissue Infections, Urinary Tract Infections
- Interventions
- As-needed follow up, Automatic follow-up
- Behavioral
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 18 Years
- Enrollment
- 2,674 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 14
- States / cities
- Phoenix, Arizona • Mountain View, California • Palo Alto, California + 10 more
- Conditions
- Osteochondral Defect
- Interventions
- osteochondral transplant on the femoral condyle
- Procedure
- Lead sponsor
- AlloSource
- Industry
- Eligibility
- 12 Years to 60 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2031
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Los Angeles, California • Redwood City, California + 3 more
- Conditions
- Amyotrophic Lateral Sclerosis, Degenerative Disorder, Motor Neuron Disease, Movement Disorders
- Interventions
- Not listed
- Lead sponsor
- Target ALS Foundation, Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2031
- U.S. locations
- 10
- States / cities
- Phoenix, Arizona • San Diego, California • Georgetown, District of Columbia + 7 more
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- Partnered Prolonged Exposure (PPE), Prolonged Exposure (PE)
- Behavioral
- Lead sponsor
- United States Department of Defense
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 420 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • San Diego, California • Minneapolis, Minnesota + 1 more
- Conditions
- Atrial Fibrillation, Overweight or Obesity
- Interventions
- Placebo, Semaglutide
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Chicago, Illinois
- Conditions
- Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension
- Interventions
- Not listed
- Lead sponsor
- Pulmonary Hypertension Association, Inc.
- Other
- Eligibility
- 0 Years and older
- Enrollment
- 3,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2025
- U.S. locations
- 52
- States / cities
- Phoenix, Arizona • Sacramento, California • San Francisco, California + 40 more
- Conditions
- Giant Cell Tumor of Bone, Sarcoma
- Interventions
- Surgery
- Procedure
- Lead sponsor
- University of Calgary
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Rochester, Minnesota